{
  "retracted": false,
  "timestamp": 1511827200000,
  "updates": [
    {
      "timestamp": 1563499386295,
      "identifier": {
        "doi": "10.1038/nrclinonc.2017.190"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1038/nrclinonc.2017.100"
  },
  "journal": "Nature Reviews Clinical Oncology",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum: Me too-drugs with limited benefits â€” the tale of regorafenib for HCC"
}
